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Received 23 November 2010; received in revised form 11 January 2011; accepted 13 January 2011; Available online 25 March 2011AbstractObjectives: The aim of this study was to determine if gender affects mortality in patients after thoracic endovascular aortic repair (TEVAR).
Methods: We retrospectively analyzed 286 consecutive patients undergoing TEVAR at our institution during a 12-year period (female 29%,
median age 69 years). Chronic health conditions, risk factors, as well as early and long-term outcome were assessed. Follow-up data were
available in all patients. Results: For female gender, 1-year survival and 5-year survival was 84% and 56% versus 83% and 60% formale gender. No
significant gender influence was observed (odds ratio (OR) 0.96, 95% confidence interval (CI) 0.59—1.56). Furthermore, no significant gender
influence could be observed according to the individual indication — atherosclerotic aneurysms (OR 0.78 95%CI 0.41—1.47), acute type B
dissections (OR 0.78 95%CI 0.21—2.83), penetrating atherosclerotic ulcers/intramural hematoma (OR 1.48 95%CI 0.53—4.19), and traumatic
aortic lesions (OR 1.48 95%CI 0.53—4.19). Age (OR 3.6 95%CI 1.24—10.45) and chronic obstructive pulmonary disease (COPD; OR 3.09 95%CI
0.98—9.73) were independent predictors of mortality in females. Conclusions: Gender does not affect mortality in patients after TEVAR
irrespective of the underlying indication, atherosclerotic aneurysms, acute type B dissections, penetrating ulcers/intramural hematoma, and
traumatic aortic lesions. Classical risk factors such as age and the presence of COPD at the time of TEVAR remain themost important risk factors
in females.
# 2011 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
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Thoracic endovascular aortic repair (TEVAR) is gaining
increased popularity for the repair of various acute and
chronic thoracic aortic pathologies [1—6]. Mid-term results
have been encouraging and several analyses have shown risk
factors for durability and survival such as arch involvement,
length of landing zones, and number of prostheses [3,7,8].
Interestingly, no report to date has focused on the influence
of gender on outcome.
The aim of this study was to determine if gender affects
mortality in patients after TEVAR.* Corresponding author. Address: Freiburgstrasse 18, 3010 Bern,
Switzerland. Tel.: +41 31 632 2376; fax: +41 31 632 2919.
E-mail address: martin.czerny@insel.ch (M. Czerny).
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2.1. Design
We retrospectively analyzed 286 consecutive patients
undergoing TEVAR at our institution during a 12-year period
(female 29%, median age 69 years). Indications for TEVAR
were atherosclerotic aneurysms in 115 patients (41%), type B
dissections in 75 patients (26%), penetrating atherosclerotic
ulcers (PAUs)/intramural hematoma (IMH) in 73 patients
(25%), and traumatic aortic lesions in 23 patients (8%).
2.2. Patient data
Clinical risk factors according to EuroSCORE stratifica-
tion were recorded (European System for Cardiac Operative
Risk Evaluation, EuroSCORE) [9]. Logistic EuroSCORE levels
were applied to estimate individual risk. DescriptiveSurgery. Published by Elsevier B.V. All rights reserved.
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Table 1. Descriptive characteristics of the cohort.
N overall = 286
Demographics
Age, median (IQR) 67 (58—74)
Female, n (%) 83 (29%)
Chronic health conditions and risk factors
Chronic obstructive pulmonary disease, n (%) 89 (32%)
Diabetes, n (%) 23 (8%)
Coronary artery disease, n (%) 68 (24%)
Extracardiac arteriopathy, n (%) 147 (51%)
Previous aortic surgery, n (%) 42 (15%)
In-hospital clinical assessment
Emergency, n (%) 136 (48%)
Suitable for open surgery, n (%) 59 (21%)
LV dysfunction (LVEF < 50%), n (%) 10 (3%)
Classification
Aneurysm, n (%) 115 (41%)
Dissection, n (%) 75 (26%)
PAU/IMH, n (%) 73 (25%)
Traumatic, n (%) 23 (8%)
EuroSCORE risk score
Additional, median (IQR) 9 (7—11)
Logistic, median (IQR) 17 (11—29)
Outcome
Follow- up in months, median (IQR) 13 (3—41)
In-hospital, n (%) 18 (6%)
Overall mortality, n (%) 79 (28%)
Unless otherwise indicated, data are number (percentage). IQR, interquartile
range; classification of chronic health conditions and risk factors according to
EuroSCORE criteria.
Table 2. Distribution of patients by different chronic health conditions and in-
hospital risk assessment stratified to gender.




Age, median (IQR) 69 (61—75) 66 (57—74) 0.11
Chronic health conditions and risk factors
Chronic obstructive pulmonary
disease, n (%)
25 (30%) 64 (32%) 0.72
Diabetes, n (%) 6 (7%) 17 (8%) 0.71
Coronary artery disease, n (%) 16 (19%) 52 (26%) 0.25
Extracardiac arteriopathy, n (%) 49 (59%) 98 (48%) 0.14
Previous aortic surgery, n (%) 20 (24%) 22 (11%) 0.004
In-hospital assessment
Emergency, n (%) 33 (40%) 103 (51%) 0.12
Unsuitable for open surgery,
n (%)
49 (59%) 143 (70%) 0.03
Logistic EuroScore, median (IQR) 18 (12—28) 17 (10—29) 0.31
Stentgraft, median (Range) 2 (1—5) 2 (1—6) 0.54
Femoral access, n (%) 60 (72%) 158 (78%) 0.09
Periprocedual complications,
n (%)
3 (4%) 4 (2%) 0.42
Outcome
Endoleak, n (%) 15 (18%) 28 (14%) 0.36
In-hospital, n (%) 7 (8%) 11 (5%) 0.34
Aortic-related death, n (%) 4 (5%) 11 (5%) 0.84
Overall mortality, n (%) 24 (29%) 55 (27%) 0.75
Unless otherwise indicated, data are number (percentage). IQR, interquartile
range; classification of chronic health conditions and risk factors according to
EuroSCORE criteria.characteristics of the patient cohort are shown in Table 1.
Patient characteristics according to gender are shown in
Table 2. Follow-up data were available in all patients.
Ninety percent of patients were followed up by our own
outpatient clinic. The remaining 10% were followed up by
well-known referring physicians, who apply the exact
follow-up algorithm as we do and who send us a detailed
work-up of the clinical course as well as the completion
computed tomography (CT) scans for our records.
2.3. Definitions
Chronic obstructive pulmonary disease (COPD) was
defined as long-term use of bronchodilators or steroids for
lung disease. Previous myocardial infarction was defined as
enzyme infarction with morphological or functional correlate
in coronary angiography or echocardiography. Peripheral
arterial occlusive disease was defined as one or more of
claudication, carotid occlusion or >50% stenosis, planned
intervention on the abdominal aorta, limb arteries, or
carotids. Renal insufficiency was defined as serum creatinine
2 mg dl1 in repeated measurements. Diabetes mellitus
was defined as serum hyperglycemia requiring sulfonylurea
intake or insulin substitution. Previous cerebrovascular
events were defined as previous minor or major neurologic
adverse events, irrespective of origin with and without
remaining morphological or functional correlate. Previousheart surgery was defined as open-heart surgery irrespective
of indication. Suitable for conventional surgery was defined
as suitability for conventional thoracic aortic surgery
according to preoperative risk stratification.
2.4. Statistical analysis
Continuous data are presented as the median and
interquartile range (IQR; range from the 25th to the 75th
percentile). Discrete data are given as counts and percen-
tages. Comparisons of continuous data were performed by
Mann—Whitney U tests and groups of categorical data were
compared by Chi-square tests.
Univariate Cox regression analysis was primarily per-
formed to assess the prognostic impact of female gender
upon outcome stratified to the classification of aortic
disease. Then, a multivariate time-dependent Cox regression
model was applied to assess the strongest independent risk
factor of outcome for female patients after adjustment for
possible confounding factors. Baseline variables were
entered into the model if they appeared imbalanced when
indicated by a p-value <0.2 or if they were clinically
established risk factors for adverse outcome. Results of the
logistic regression model are given as the odds ratio (OR) and
the 95% confidence interval (95%CI). Regression diagnostics
and overall model fit were performed according to standard
procedures. A two-sided p-value <0.05 was considered
statistically significant. Calculations were performed with
SPSS for Mac OsX (version 16.0).
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[()TD$FIG]3. Results
3.1. Chronic health conditions and risk factors
The incidence of COPD was balanced in both males and
females (32% vs 30%, p = 0.72). The incidence of previous
aortic surgery was significantly higher in women (24% vs 11%,
p = 0.004). Men were more likely to be unsuitable for
conventional surgery (70% vs 59%, p = 0.03).
3.2. All-cause mortality
There was no significant difference in in-hospital mortal-
ity between males and females (5% vs 8%, p = 0.34). Overall
mortality during a median period of 13 months (IQR: 3—41)
was comparable (27% vs 29%, p = 0.75). Fig. 1 shows the all-
cause mortality during follow-up.
There were no differences regarding mortality between
males and females according to the individual indication. For
female gender, 1-year survival and 5-year survival was 84%
and 56% versus 83% and 60% for male gender. No significant
gender influence was observed (OR 0.96 95%CI 0.59—1.56).
3.2.1. Aneurysms
For female gender, 1-year survival and 5-year survival was
91% and 55% versus 82% and 53% for male gender. No
significant gender influence was observed (OR 0.78 95%CI
0.41—1.47).
3.2.2. Dissections
For female gender, 1-year survival and 5-year survival was
82% and 82% versus 89% and 67% for male gender. No
significant gender influence was observed (OR 0.78 95%CI
0.21—2.83).
3.2.3. PAUs/IMH
For female gender, 1-year survival was 72% versus 79% and
5-year survival of 56% for male gender. No significant gender
influence was observed (OR 1.48 95%CI 0.53—4.19).
[()TD$FIG]Fig. 1. All-cause mortality of patients after TEVAR.3.2.4. Traumatic lesions
No significant gender influence was observed (OR 1.48
95%CI 0.53—4.19).
3.3. Aortic-related mortality
For female gender, 1-year survival and 5-year survival was
95% versus 97% and 91% for male gender (Fig. 2). No
significant gender influence was observed (OR 0.65 95%CI
0.18—2.34). Accordingly, no differences were observed
regarding the individual indication: Aneurysms (OR 0.02
95%CI 0.0—49.21), dissections (OR 2.50 95%CI 0.35—17.86),
PAUs/IMH (OR 2.50 95%CI 0.16—40.01), and traumatic lesions
(OR 0.05 95%CI 0.0—1.63) (Table 3).
3.4. Multivariate logistic regression analysis
The strongest independent risk factor for overall mortality
stratified to female gender was age (OR 3.60 95%CI 1.24—
10.45) as well as the presence of COPD at the time of TEVAR
(OR 3.09, CI 0.98—9.73) (Table 4). Extracardiac arteriopathy
(OR 0.81 95%CI 0.24—2.79), previous aortic surgery (OR 1.58
95%CI 0.54—4.60), and emergency TEVAR (OR 1.65 95%CI
0.48—5.64) did not affect mortality.4. Discussion
Gender does not affect mortality in patients after TEVAR
irrespective of the underlying indication, atherosclerotic
aneurysms, acute type B dissections, PAUs/IMH, and trau-
matic aortic lesions. Classical risk factors such as age and the
presence of COPD at the time of TEVAR remain the most
important risk factors in females.
An increasing number of reports on mid- and long-term
results after TEVAR are now available revealing conflicting
data regarding mortality. In a recent report at 4.5 years ofFig. 2. Aortic-related mortality of patients after TEVAR.
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Table 3. Distribution of female patients by different chronic health conditions and in-hospital risk assessment stratified to aortic disease morphology/etiology.
Aneurysm
N = 38 (46%)
Dissection
N = 23 (28%)
PAU/IMH
N = 21 (25%)
Traumatic *
N = 1 (1%)
p
Demographics
Age, median (IQR) 73 (69—77) 61 (48—69) 68 (61—77) 61 0.40
Chronic health conditions and risk factors
Chronic obstructive pulmonary disease, n (%) 19 (50%) 1 (4%) 4 (19%) 0 (0%) <0.001
Diabetes, n (%) 5 (13%) 1 (4%) 0 (0%) 0 (0%) 0.15
Coronary artery disease, n (%) 12 (32%) 2 (9%) 2 (10%) 0 (0%) 0.04
Extracardiac arteriopathy, n (%) 33 (87%) 8 (35%) 8 (38%) 0 (0%) <0.001
Previous aortic surgery, n (%) 13 (34%) 3 (13%) 4 (19%) 0 (0%) 0.15
In-hospital assessment
Emergency, n (%) 4 (11%) 17 (74%) 11 (52%) 0 (0%) <0.001
Suitable for open surgery, n (%) 2 (5%) 6 (26%) 1 (4%) 1 (100%) <0.001
Logistic EuroScore, median (IQR) 18 (12—28) 14 (10—26) 28 (13—39) 7 0.35
Stentgraft, median (Range) 2 (1—5) 1 (1—4) 1 (1—2) 1 0.003
Femoral access, n (%) 25 (66%) 21 (91%) 13 (62%) 1 (100%) 0.008
Periprocedual complications, n (%) 1 (3%) 1 (4%) 1 (5%) 0 (0%) 0.89
Outcome
Endoleak, n (%) 11 (29%) 2 (9%) 2 (6%) 0 (0%) 0.07
30-day mortality, n (%) 2 (5%) 2 (9%) 3 (14%) 0 (0%) 0.49
Aortic disease related death, n (%) 1 (3%) 2 (9%) 1 (5%) 0 (0%) 0.57
Unless otherwise indicated, data are number (percentage). IQR, interquartile range; classification of chronic health conditions and risk factors according to
EuroSCORE criteria. *Excluded from group comparison.follow-up, actuarial survival at 1, 5, and 8 years was 82%,
49%, and 27%, respectively [10]. By contrast, others report
actuarial survival rates after 3.6 years of follow-up at 1, 3,
and 5 years of 96%, 86%, and 69% [2]. The main difference
seems to be evolving technology and better indications as the
first report merely included first-generation devices and
patients being treated early in TEVAR history. However,
gender was not addressed, due to the low patient number. In
this series, overall mortality compared favorably with the
recent literature [10,11]. No gender-related difference could
be found with regard to mortality, indicating no increased
risk in females such as after other cardiovascular interven-
tions [12].
Several known risk factors contribute to the development
of acute and chronic thoracic aortic pathology. COPD may act
as the most important risk factor due to recurring episodes of
abrupt changes in intrathoracic pressure. Advanced disease
stages may prevent conventional open surgical treatment. InTable 4. Multivariate Cox-regression model assessing the strongest indepen-
dent risk factor for overall mortality in female patients.
Risk factor for mortality Odds ratio 95%CI p-Value
Female gender
Age > 75 years 3.60 1.24—10.45 0.01
Chronic obstructive pulmonary disease 3.09 0.98—9.73 0.05
Diabetes 0.91 0.16—5.24 0.91
Coronary artery disease 0.39 0.10—1.49 0.17
Extracardiac arteriopathy 0.81 0.24—2.79 0.74
Previous aortic surgery 1.58 0.54—4.60 0.41
Emergency 1.65 0.48—5.64 0.43
Stentgraft > 1 0.81 0.76—2.41 0.71
Endoleak 1.02 0.34—3.12 0.97this series, 30% of females as well as males suffered from
severe COPD. Severe COPD, defined as forced expiratory
volume in 1 s (FeV1) below 0.7 l, has been shown to be an
independent predictor of mortality independent of aortic
pathology by others [13,14].
Women had a lower incidence of extracardiac arterio-
pathy but a higher incidence of previous aortic surgery. The
first finding seems reasonable, as age was comparable
between females and males. It is known that women are
affected by atherosclerosis 10 years later than males [15]. It
may be a specific finding of this report that more women had
undergone previous aortic surgery. When analyzing our data,
we found that the majority of women had undergone
ascending or hemiarch replacement and the number of
infrarenal replacements was low.
Women were more likely to be suitable for conventional
open aortic surgery then men. Suitability for open repair
remains a subjective decision of the treating physician to
date. Several factors contribute to the decision. One of the
most important details of this decision-making process may
be the avoidance of deep hypothermic circulatory arrest
(DHCA), which is associated with bleeding disorders as well as
impaired gas exchange, especially in the left lung in the
immediate postoperative period [16]. As previous ascending
or hemiarch replacement may compel the utilization of
DHCA, this fact may have well contributed to this result.
Logistic European System for Cardiac Operative Risk Evalua-
tion (EuroSCORE) levels showed no tendency toward higher
levels in women. This is interesting as female gender per se is
associated with increased risk in the EuroSCORE stratification
system [9].
We have seen a well-balanced proportion of endoleaks
regarding types and numbers as well as consequence
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regarding these parameters as well as need for secondary
surgical interventions are addressed in detail in other reports
from our group [7,17]. A more detailed description of these
parameters would — in our impression — defocus the article
and would exceed its frame. Actually, cumulative rate of
endoleak formation was comparable throughout the entire
study period. Our rate of endoleak formation is acceptably
low and well comparable with recent reports [18]. Improved
understanding of factors associated with endoleak formation
requiring treatment has contributed to these stable results.
Most importantly, aortic-related mortality was low.
Age turned out to be an independent risk factor in
females, most likely due to the increased frailty and limited
natural life expectancy of advanced age in combination with
an underlying thoracic aortic pathology even after successful
treatment [19]. Furthermore, COPD was an independent
predictor of mortality in females. This has also been shown in
several investigations in patients without thoracic aortic
pathology [13,14].5. Strengths and limitations
This study is the first addressing gender aspects after
TEVAR. Nevertheless, this analysis should be viewed in the
light of its limitations. First, this study is a single-center study
and retrospective in its nature. Furthermore, amore detailed
analysis with regard to gender-specific risk according to the
individual indication for TEVAR is warranted. However, this
study is a first step to shed light on this important field of
evolving knowledge.
Summarizing, gender does not affect mortality in patients
after TEVAR irrespective of the underlying indication,
atherosclerotic aneurysms, acute type B dissections, PAUs/
IMH, and traumatic aortic lesions. Classical risk factors such
as age and the presence of COPD at the time of TEVAR remain
the most important risk factors in females.
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